Millions who suffer from the nightly disruptions of obstructive sleep apnea may soon have a new treatment option beyond the standard CPAP machine. European researchers have announced promising results from a clinical trial evaluating sulthiame, a medication already used to treat epilepsy, as a potential therapy for this common sleep disorder. The findings, published in The Lancet, suggest the drug could significantly reduce breathing interruptions and improve oxygen levels during sleep.
Obstructive sleep apnea, affecting an estimated up to 1 billion people worldwide, occurs when the muscles in the throat relax during sleep, causing a collapse of the airway. This leads to pauses in breathing, fragmented sleep, and a drop in blood oxygen levels. Untreated sleep apnea is linked to serious health risks, including high blood pressure, heart disease, stroke, and Type 2 diabetes.
Currently, the most widely used treatment is continuous positive airway pressure (CPAP) therapy, which involves wearing a mask that delivers pressurized air to retain the airway open. However, many patients find CPAP uncomfortable and difficult to tolerate, with approximately half discontinuing apply within a year. This has driven the search for alternative, more convenient treatments.
The new research focuses on sulthiame, an anti-seizure medication that researchers believe may stabilize breathing signals in the brain, reducing airway collapse. Whereas already approved for certain types of epilepsy in children, its potential application for sleep apnea is a relatively recent area of investigation.
Significant Reduction in Breathing Interruptions Observed in Trial
The European clinical trial, involving 298 participants with moderate to severe obstructive sleep apnea from four countries, employed a double-blind design. This means neither the participants nor the researchers knew who was receiving the active drug versus a placebo. Participants were randomly assigned to receive different doses of sulthiame or a placebo. According to ScienceDaily, those receiving higher doses of sulthiame experienced up to a 47 percent reduction in nighttime breathing interruptions compared to the placebo group.
In addition to fewer breathing pauses, participants taking sulthiame similarly demonstrated improved oxygen levels during sleep. Researchers reported that the medication was generally well-tolerated, with most side effects being mild, and temporary. This suggests a potentially favorable safety profile for the drug.
How Sulthiame May Work
Experts believe sulthiame works by influencing the body’s control of breathing. Jan Hedner, a senior professor of pulmonary medicine at the Sahlgrenska Academy at the University of Gothenburg in Sweden, explained that the drug appears to strengthen the signal to breathe, helping to prevent the upper airway from collapsing during sleep. “We have been working on this treatment strategy for a long time, and the results reveal that sleep apnea can indeed be influenced pharmacologically,” Hedner said, as reported by Powers Health.
This approach differs from CPAP, which physically forces the airway open. Sulthiame aims to address the underlying neurological control of breathing, potentially offering a more natural and comfortable solution for some patients.
What’s Next for Sulthiame as a Sleep Apnea Treatment?
While these initial findings are encouraging, researchers emphasize that sulthiame is not yet ready for widespread use. Larger and longer-term studies are needed to confirm its long-term safety and effectiveness. Scientists from the University of Gothenburg, including Ludger Grote and Kaj Stenlöf, are continuing to investigate the drug’s potential. The team hopes to determine if the observed benefits are sustained over time and if the treatment is safe for a broader range of patients.
The development of a pill-based treatment for obstructive sleep apnea would represent a significant advancement in the field, offering a potentially more accessible and convenient option for the millions who struggle with this condition. However, further research is crucial to fully understand the drug’s benefits and risks.
Disclaimer: This article provides informational content about medical research and is not intended to be a substitute for professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment of any medical condition.
What are your thoughts on this potential new treatment option? Share your comments below, and please share this article with anyone who might find it helpful.
